BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Acetaminophen, rs2476601, FOXP1, glucose metabolic process, Inflammatory disorder)
Bookmark Forward

QuickView for CUL3 (gene)


Body Atlas

Most Correlated Tissues

  1. Testes
  2. Testis seminiferous tubule
  3. Basophil of peripheral blood
  4. Dendritic (plasmacytoid) cell
  5. Eosinophil of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Varicella-zoster virus infection
  2. Pyloric ulcer
  3. Drug resistance
  4. Periodontitis
  5. Hypertrophic cardiomyopathy
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. pyrvinium
  2. 1-amino-2,4-dibromoanthraquinone
  3. Scopolamine Hydrobromide
  4. tris(2,3-dibromopropyl)phosphate
  5. 2-chloro-5-nitrobenzanilide
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. H2-Eb2
  2. RPL35
  3. WNT8A
  4. HLA-DQA1
  5. DDOST
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hyper…
  2. Are CUL3 variants an underreported cause of congenital heart disease?
  3. Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension.
  4. A novel splice site CUL3 variant in a patient with neurodevelopmental delay.
  5. Structure and Function of RhoBTB1 Required for Substrate Specificity and Cullin-3 Ubiquitination.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer
  2. Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT…
  3. Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
  4. ADAPT: Efficacy of a Dietary Supplement During and After Exercise
  5. Osimertinib and Etoposide as First-Line Treatment in Osimertinib-Resistant Advanced EGFR-Mutant NSCL…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.